[The usefulness of 99mTc-MIBI scintigraphy in a patient with hyperparathyroidism who underwent percutaneous ethanol injection therapy].
99mTc-MIBI scintigraphy was performed in a 67-year-old male with hyperparathyroidism who underwent percutaneous ethanol injection therapy (PEIT). Abnormal 99mTc-MIBI uptake was clearly recognized. 99mTc-MIBI scintigraphy was useful also in the evaluation of hyperparathyroidism after imperfect PEIT.
Ohta
H
H
Department of Radiology, Osaka Red Cross Hospital.
D000368:Aged; D000431:Ethanol / Q000008:administration & dosage*; D006801:Humans; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging* / Q000628:therapy*; D015552:Injections, Intralesional; D008297:Male; D010280:Parathyroid Glands / Q000000981:diagnostic imaging / Q000378:metabolism; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012597:Sclerosing Solutions / Q000008:administration & dosage*; D015911:Sclerotherapy; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics
D019275:Radiopharmaceuticals; D012597:Sclerosing Solutions; D000431:Ethanol; D017256:Technetium Tc 99m Sestamibi